{"timestamp": 1771609027.4709349, "value": {"ticker": "CNTX", "company_name": "Context Therapeutics Inc.", "short_name": "Context Therapeutics Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 213159680, "float_shares": 42717386, "shares_outstanding": 91879177, "short_ratio": 0.29, "short_percent_of_float": 0.0094, "shares_short": 716437, "shares_short_prior": 418668, "insider_percent_held": 0.01181, "institution_percent_held": 0.76711, "total_cash": 76938184, "total_debt": 140200, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0.192, "current_ratio": 13.098, "book_value": 0.796, "price_to_book": 2.9145727, "operating_cashflow": -22349156, "free_cashflow": -14823796, "price": 2.32, "52w_high": 2.85, "52w_low": 0.49, "avg_volume": 1484435, "avg_volume_10d": 1661840, "full_time_employees": 12, "audit_risk": 0, "overall_risk": 0}}